Spero Therapeutics, Inc. Profile Avatar - Palmy Investing

Spero Therapeutics, Inc.

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product can…

Biotechnology
US, Cambridge [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Spero Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Spero Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Spero Therapeutics, Inc..

End of SPRO's Analysis
CIK: 1701108 CUSIP: 84833T103 ISIN: US84833T1034 LEI: - UEI: -
Secondary Listings
SPRO has no secondary listings inside our databases.